Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
语言
全文检索
题名
作者
主题
索引号
ISBN/ISSN
标签
检索
高级检索
Osteoprotegerin inhibits the d...
引用
发送短信
推荐此
打印
导出纪录
导出到 RefWorks
导出到 EndNoteWeb
导出到 EndNote
Permanent link
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Show other versions (1)
书目详细资料
Main Authors:
Croucher, P
,
Shipman, C
,
Perry, M
,
Lippitt, J
,
Asosingh, K
,
van Beek, E
,
Van Camp, B
,
Russell, R
,
Dunstan, C
,
Vanderkerken, K
格式:
Journal article
出版:
2001
持有资料
实物特征
Other Versions (1)
相似书籍
职员浏览
相似书籍
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
由: Croucher, P, et al.
出版: (2001)
Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
由: Croucher, P, et al.
出版: (2000)
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
由: Croucher, P, et al.
出版: (2003)
Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
由: Croucher, P, et al.
出版: (2001)
Osteoprotegerin and the development of myeloma bone disease
由: Croucher, P, et al.
出版: (2004)